Zobrazeno 1 - 10
of 26
pro vyhledávání: '"A. O. Koneva"'
Publikováno v:
Human Sport Medicine. 19:92-102
Aim. The purpose of the article is to introduce innovative approaches to training female basketball players for responding and resolving conflict situations, reducing aggressiveness, building effective interpersonal relationships during training to a
Autor:
O. Ovsyannikova, O. Koneva, L. Garzanova, L. P. Ananyeva, R. Shayakhmetova, O. Desinova, A. Khelkovskaia-Sergeeva, M. Starovoytova
Publikováno v:
Annals of the Rheumatic Diseases. 81:1489.1-1489
BackgroundSystemic sclerosis (SSc) is a multiorgan disease wherein the pathogenic processes of inflammation, vasculopathy and fibrosis lead to multiple disease manifestations. The course of SSc is often one of progressive damage to multiple organs in
Autor:
L. Garzanova, L. P. Ananyeva, O. Koneva, O. Ovsyannikova, O. Desinova, M. Starovoytova, R. Shayakhmetova
Publikováno v:
Annals of the Rheumatic Diseases. 81:751.1-751
BackgroundNowadays, there is already published a lot of data on the treatment of systemic sclerosis (SSc) with rituximab (RTX). Recent studies reported about improvement of skin fibrosis and interstitial lung disease associated with SSc (ILD-SSc) on
Autor:
O. Desinova, M. Starovoytova, A. Khelkovskaia-Sergeeva, L. P. Ananyeva, O. Koneva, R. Shayakhmetova, L. Garzanova, O. Ovsyannikova
Publikováno v:
Annals of the Rheumatic Diseases. 81:1493.2-1493
BackgroundSystemic Sclerosis-polymyositis/dermatomyositis overlap syndrome (SSc-PM/DM) occurs in 10 to 37% of cases and has great differential diagnostic difficulties. Muscle damage in SSc-PM/DM is represented by myositis with primary inflammatory an
Autor:
A. Khelkovskaia-Sergeeva, L. Garzanova, M. Starovoytova, O. Desinova, L. P. Ananyeva, O. Koneva
Publikováno v:
Annals of the Rheumatic Diseases. 81:1496.2-1496
BackgroundInterstitial lung disease (ILD) is the most common internal organ manifestation of idiopathic inflammatory myopathies (IIM) that can severely affect the course of the disease.ObjectivesTo describe lung functions in IIM patients with ILD dur
Publikováno v:
Annals of the Rheumatic Diseases. 81:1460.2-1460
BackgroundThe low prevalence of pregnancy in women with systemic sclerosis (SSc) is due to multi-factorial causes, including premature ovarian insufficiency (POI). Anti-Mullerian hormone (AMH) is one of the primary parameters for assessing reproducti
Autor:
O. Ovsyannikova, O. Koneva, L. Garzanova, L. P. Ananyeva, A. Khelkovskaia-Sergeeva, R. Shayakhmetova, O. Desinova, M. Starovoytova
Publikováno v:
Annals of the Rheumatic Diseases. 81:1791.2-1791
BackgroundInterstitial lung disease (ILD) is one of the most relevant extra-articular manifestations of rheumatic diseases resulting in a substantial increase in morbidity and mortality. High-resolution computed tomography (HRCT), which is the curren
Autor:
O. Koneva, L. Garzanova, O. Ovsyannikova, N. Kovaleva, L. P. Ananyeva, O. Desinova, M. Starovoytova, R. Shayakhmetova
Publikováno v:
Annals of the Rheumatic Diseases. 81:1490.2-1490
BackgroundHRCT is the gold standard for confirming ILD.However,the role of HRCT for estimating the effectiveness of therapy is not determined in full.ObjectivesTo assess the dynamics of X-ray changes and PFTs during IST in pts with SSc and different
Autor:
L. Garzanova, L. P. Ananyeva, O. Koneva, O. Desinova, O. Ovsyannikova, M. Starovoytova, R. Shayakhmetova, A. Khelkovskaia-Sergeeva
Publikováno v:
Annals of the Rheumatic Diseases. 81:1479.2-1479
BackgroundRituximab (RTX) has shown itself as an effective option in treatment of interstitial lung disease associated with systemic sclerosis (ILD-SSc). However, there is not enough data on the effect of rituximab biosimilars in patients (pts) with
Autor:
O. Ovsyannikova, O. Koneva, L. Garzanova, S. Glukhova, L. P. Ananyeva, A. Khelkovskaia-Sergeeva
Publikováno v:
Annals of the Rheumatic Diseases. 81:1792.1-1792
BackgroundPulmonary disease is one of the most relevant with interstitial lung disease (ILD) being one of the most frequents forms of involvement with resultant worsening of morbidity and mortality in disorders such as systemic sclerosis (SSc), rheum